PharmaBlock (Stock Code:300725.SZSE) is a CDMO recognized as a pioneer in innovative green technology and a reliable partner in providing chemistry services throughout the pharmaceutical R&D process and commercial production. Its businesses start from the legacy of rationally designed building blocks that are supplied from discovery through development & commercial. Within the last few years, leveraging its unique advantages of quick access to in-house building blocks and chemistry expertise, PharmaBlock has extended its business scope from a building block supplier to a more comprehensive CDMO services and solutions provider. Coupled with low-carbon technologies such as flow chemistry & biocatalysis, it has gained a reputation as a quality manufacturer of RSMs, intermediates, and APIs with a lower cost and greener footprint.

Building Blocks
The team has generated a large and unique collection of high-quality and diverse building blocks, that cater to the majority of R&D needs for small molecule drugs and new modalities like peptide, oligonucleotide, ADC and TPD drugs.

CDMO
- From pre-IND to post-NDA, covering small molecule drugs and new modalities like peptide, ADC and TPD drugs.
- Fit-for-purpose development.
- 700 m3 cost effective GMP manufacturing; continuous flow manufacturing to dramatically enlarge the actual capacity
- FDA inspected with no Form 483 issued
- Equipped with OEB-5 research lab (gram scale) and GMP facility (kilo scale) to handle high-potency compounds safely, with strict adherence to Occupational Exposure Limits (OEL) as low as 50 ng/m³